NO920176L - Antagonister av gm-csf avledet fra karboksylterminalen - Google Patents

Antagonister av gm-csf avledet fra karboksylterminalen

Info

Publication number: NO920176L
Authority: NO; Norway
Prior art keywords: carboxyl terminal; csf antagonists; antagonists derived; derived; csf
Prior art date: 1989-07-14

Application number

NO92920176A

Other languages

English (en)

Norwegian (no)

Other versions

NO920176D0 (no

Inventor

Gail Foure Seelig

Julie Ellen Scheffler

Paul Phillip Trotta

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-14

Filing date

1992-01-14

Publication date

1992-01-14

1992-01-14 Application filed by Schering Corp filed Critical Schering Corp

1992-01-14 Publication of NO920176D0 publication Critical patent/NO920176D0/no

1992-01-14 Publication of NO920176L publication Critical patent/NO920176L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO92920176A 1989-07-14 1992-01-14 Antagonister av gm-csf avledet fra karboksylterminalen NO920176L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US37984689A	1989-07-14	1989-07-14
PCT/US1990/003811 WO1991001330A1 (en)	1989-07-14	1990-07-12	Antagonists of gm-csf derived from the carboxyl terminus

Publications (2)

Publication Number	Publication Date
NO920176D0 NO920176D0 (no)	1992-01-14
NO920176L true NO920176L (no)	1992-01-14

Family

ID=23498958

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO92920176A NO920176L (no)	1989-07-14	1992-01-14	Antagonister av gm-csf avledet fra karboksylterminalen

Country Status (16)

Country	Link
US (1)	US5475087A (de)
EP (2)	EP0482086A1 (de)
JP (1)	JPH04503815A (de)
KR (1)	KR920701246A (de)
AU (1)	AU630496B2 (de)
CA (1)	CA2062975A1 (de)
FI (1)	FI920150A0 (de)
HU (1)	HUT63181A (de)
IE (1)	IE902562A1 (de)
IL (1)	IL95061A0 (de)
MY (1)	MY105946A (de)
NO (1)	NO920176L (de)
NZ (1)	NZ234479A (de)
PH (1)	PH27534A (de)
WO (1)	WO1991001330A1 (de)
ZA (1)	ZA905480B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2060741A1 (en) *	1991-02-11	1992-08-12	Robert S. Greenfield	Gm-csf inhibiting oligopeptides
AU5611394A (en) *	1992-11-19	1994-06-08	Dana-Farber Cancer Institute	Antibodies for gm-csf receptor and uses thereof
DK96493D0 (da) *	1993-08-26	1993-08-26	Mouritsen Og Elsner Aps	Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
FR2730154B1 (fr) *	1995-02-08	1997-07-11	Stephanois Rech	Dispositif de mesure des efforts exerces lors de la marche
AUPN378095A0 (en) *	1995-06-23	1995-07-20	Bresagen Limited	Haemopoietic growth factor antagonists and uses therefor
US8062637B2 (en) *	2000-05-08	2011-11-22	Morphosys Ag	Methods of ameliorating inflammatory disease using an uPA antagonist
US7455836B2 (en) *	2000-05-08	2008-11-25	The University Of Melbourne	Method of treatment and agents useful for same
US7247618B2 (en) *	2001-04-30	2007-07-24	Tripathi Rajavashisth	Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
AR045563A1 (es)	2003-09-10	2005-11-02	Warner Lambert Co	Anticuerpos dirigidos a m-csf
EP1712241A1 (de)	2005-04-15	2006-10-18	Centre National De La Recherche Scientifique (Cnrs)	Intratumoral applizierbare Zusammensetzung zur Krebsbehandlung
AU2005100402B4 (en) *	2005-05-16	2006-01-12	Novomatic Ag	Method for increased chances at an award on a Gaming Machine
US7741450B2 (en)	2006-02-08	2010-06-22	Morphotek Inc.	Antibodies to GM-CSF
AU2013201228B2 (en) *	2006-02-08	2016-01-21	Eisai, Inc.	Antigenic gm-csf peptides and antibodies to gm-csf
US8398972B2 (en)	2006-11-21	2013-03-19	Kalobios Pharmaceuticals, Inc.	Methods of treating dementia using a GM-CSF antagonist
EP2101780B1 (de) *	2006-11-21	2013-10-09	Kalobios Pharmaceuticals, Inc.	Verfahren zur behandlung chronischer entzündungskrankheiten mithilfe eines gm-csf-agonisten
TW200918553A (en) *	2007-09-18	2009-05-01	Amgen Inc	Human GM-CSF antigen binding proteins
CN104072613A (zh)	2007-11-13	2014-10-01	Evec股份有限公司	与hGM-CSF结合的单克隆抗体及包含它的药物组合物
CN102271705A (zh)	2008-12-22	2011-12-07	墨尔本大学	骨关节炎治疗
CA2747206C (en)	2008-12-22	2018-04-24	The University Of Melbourne	Pain treatment
WO2013026059A1 (en)	2011-08-18	2013-02-21	New York University	Inhibition of oncogenic kras-induced gm-csf production and function
CA2856329A1 (en) *	2011-11-17	2013-05-23	Glia Sp Z.O.O.	Compositions and methods for treating glioma
EP4291380A1 (de)	2021-02-15	2023-12-20	Splifar S.A.	Verfahren zum aufbringen einer dichtung auf eine platte
CN119144565B (zh) *	2023-11-24	2025-11-25	成都赛恩吉诺生物科技有限公司	表达GM-CSF的exon 2功能区的免疫工程细胞及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI83662C (fi) *	1980-07-17	1991-08-12	Scripps Clinic Res	Diagnostik antikropp och foerfarande foer dess framstaellning.
UA39161C2 (uk) *	1984-07-06	2001-06-15	Новартіс Аг	Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують
AU588819B2 (en) *	1984-10-29	1989-09-28	Immunex Corporation	Cloning of human granulocyte-macrophage colony stimulating factor gene

1990
- 1990-07-12 EP EP90911581A patent/EP0482086A1/de active Pending
- 1990-07-12 FI FI920150A patent/FI920150A0/fi not_active Application Discontinuation
- 1990-07-12 ZA ZA905480A patent/ZA905480B/xx unknown
- 1990-07-12 KR KR1019910700279A patent/KR920701246A/ko not_active Withdrawn
- 1990-07-12 CA CA002062975A patent/CA2062975A1/en not_active Abandoned
- 1990-07-12 HU HU9287A patent/HUT63181A/hu unknown
- 1990-07-12 NZ NZ234479A patent/NZ234479A/en unknown
- 1990-07-12 WO PCT/US1990/003811 patent/WO1991001330A1/en not_active Ceased
- 1990-07-12 IL IL95061A patent/IL95061A0/xx unknown
- 1990-07-12 JP JP2511280A patent/JPH04503815A/ja active Pending
- 1990-07-12 PH PH40830A patent/PH27534A/en unknown
- 1990-07-12 MY MYPI90001168A patent/MY105946A/en unknown
- 1990-07-12 AU AU61487/90A patent/AU630496B2/en not_active Ceased
- 1990-07-12 EP EP90113375A patent/EP0409091A1/de not_active Withdrawn
- 1990-07-13 IE IE256290A patent/IE902562A1/en unknown
1992
- 1992-01-14 NO NO92920176A patent/NO920176L/no unknown
1994
- 1994-02-04 US US08/192,310 patent/US5475087A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0482086A1 (de)	1992-04-29
IE902562A1 (en)	1991-02-27
NO920176D0 (no)	1992-01-14
FI920150A7 (fi)	1992-01-14
FI920150A0 (fi)	1992-01-14
ZA905480B (en)	1991-03-27
KR920701246A (ko)	1992-08-11
US5475087A (en)	1995-12-12
HUT63181A (en)	1993-07-28
HU9200087D0 (en)	1992-04-28
IL95061A0 (en)	1991-06-10
AU630496B2 (en)	1992-10-29
MY105946A (en)	1995-02-28
JPH04503815A (ja)	1992-07-09
CA2062975A1 (en)	1991-01-15
PH27534A (en)	1993-08-18
WO1991001330A1 (en)	1991-02-07
NZ234479A (en)	1992-03-26
AU6148790A (en)	1991-02-22
EP0409091A1 (de)	1991-01-23

Publication	Publication Date	Title
NO920176L (no)	1992-01-14	Antagonister av gm-csf avledet fra karboksylterminalen
DE69005755D1 (de)	1994-02-17	Strommessschaltung.
DE69131712D1 (de)	1999-11-18	Lottragender anschlussdraht
DE69011756D1 (de)	1994-09-29	Stromspiegelschaltung.
NO178643C (no)	1996-05-02	Klemmekonstruksjon
FI913251A0 (fi)	1991-07-04	Renad kiliarisk neurotrofisk faktor.
BR8800710A (pt)	1988-10-04	Supressor de sobretensoes
ATA247090A (de)	1994-05-15	Klemmanordnung
MX9100717A (es)	1992-04-01	Antagonistas de la bradiquinina
DE59204995D1 (de)	1996-02-22	Anschlussklemme
DE69320749D1 (de)	1998-10-08	Strommessschaltung
DE69007708D1 (de)	1994-05-05	Drahtverbindungsapparat.
NO890904D0 (no)	1989-03-02	Video-terminal.
BR9005427A (pt)	1991-09-17	Prendedor terminal
ATE132871T1 (de)	1996-01-15	Bis-arylphosphatester-antagonisten vom thrombocyten aktivierenden faktor
NO901257D0 (no)	1990-03-19	Kinolinderivater.
DE69029922D1 (de)	1997-03-27	Bi-CMOS-Schaltung
FR2609585B1 (fr)	1991-03-15	Circuit realisant la fonction ou-exclusif
FI891447A7 (fi)	1990-09-29	Bilutstaellningsstativ.
DK0418863T3 (da)	1995-03-20	NMDA-antagonister
FI920925A7 (fi)	1992-02-28	Substituoidut kinoliinit
FI930108A0 (fi)	1993-01-12	Imidazopyridin-paf-antagonister
FI922315A0 (fi)	1992-05-21	Jännitteenmittauspiiri
DE69011695D1 (de)	1994-09-29	Hochspannungsverbindungsdraht.
KR950700884A (ko)	1995-02-20	루코트리엔 길항제로서의 퀴놀린 유도체(Quinoline derivatives as leukotriene antagonists)